Cost-effectiveness analysis of treatments to reduce cholesterol concentration, blood pressure and smoking for the prevention of coronary heart disease

被引：0
|
作者：
Plans-Rubió, P [1 ]
机构：
[1] Dept Sanitat Catalonia SCS, Barcelona, Spain
来源：
VALUE IN HEALTH | 2002年 / 5卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61288-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：484 / 484
页数：1
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF ANTIHYPERLIPEMIC THERAPY IN THE PREVENTION OF CORONARY HEART-DISEASE - THE CASE OF CHOLESTYRAMINE
    OSTER, G
    EPSTEIN, AM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (17): : 2381 - 2387
  • [32] COST-EFFECTIVENESS PERSPECTIVES IN CORONARY HEART-DISEASE
    GOLDMAN, L
    AMERICAN HEART JOURNAL, 1990, 119 (03) : 733 - 740
  • [33] Cost-effectiveness analysis of salt reduction policies to reduce coronary heart disease in Syria, 2010-2020
    Wilcox, Meredith L.
    Mason, Helen
    Fouad, Fouad M.
    Rastam, Samer
    al Ali, Radwan
    Page, Timothy F.
    Capewell, Simon
    O'Flaherty, Martin
    Maziak, Wasim
    INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2015, 60 : S23 - S30
  • [34] Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care
    Turner, D. A.
    Paul, S.
    Stone, M. A.
    Juarez-Garcia, A.
    Squire, I.
    Khunti, K.
    HEART, 2008, 94 (12) : 1601 - 1606
  • [35] A NEW METHOD OF ESTIMATING COST-EFFECTIVENESS OF CHOLESTEROL REDUCTION THERAPY FOR PREVENTION OF HEART-DISEASE
    KINLAY, S
    OCONNELL, D
    EVANS, D
    HALLIDAY, J
    PHARMACOECONOMICS, 1994, 5 (03) : 238 - 248
  • [36] Cost effectiveness of treating low HDL-cholesterol in the primary prevention of coronary heart disease
    Joel W. Hay
    Kimberly L. Sterling
    PharmacoEconomics, 2005, 23 : 133 - 141
  • [37] Cost effectiveness of treating low HDL-cholesterol in the primary prevention of coronary heart disease
    Hay, JW
    Sterling, KL
    PHARMACOECONOMICS, 2005, 23 (02) : 133 - 141
  • [38] Cost-effectiveness of Pravastatin in secondary prevention of coronary artery disease
    Ashraf, T
    Hay, JW
    Pitt, B
    Wittels, E
    Crouse, J
    Davidson, M
    Furberg, CD
    Radican, L
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (04): : 409 - 414
  • [39] Cost-Effectiveness Analysis of The Real Cost Campaign's Effect on Smoking Prevention
    MacMonegle, Anna J.
    Nonnemaker, James
    Duke, Jennifer C.
    Farrelly, Matthew C.
    Zhao, Xiaoquan
    Delahanty, Janine C.
    Smith, Alexandria A.
    Rao, Pamela
    Allen, Jane A.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2018, 55 (03) : 319 - 325
  • [40] Combined effects of systolic blood pressure, serum cholesterol and smoking on coronary heart disease and stroke
    Thulasimani, M
    Ramaswamy, S
    EUROPEAN HEART JOURNAL, 2002, 23 (23) : 1887 - 1888
12345